Codexis, Inc. (CDXS)
NASDAQ: CDXS · Real-Time Price · USD
1.230
-0.030 (-2.38%)
At close: Mar 6, 2026, 4:00 PM EST
1.280
+0.050 (4.07%)
After-hours: Mar 6, 2026, 4:58 PM EST
Codexis Employees
Codexis had 188 employees as of December 31, 2024. The number of employees increased by 14 or 8.05% compared to the previous year.
Employees
188
Change (1Y)
14
Growth (1Y)
8.05%
Revenue / Employee
$281,553
Profits / Employee
-$340,165
Market Cap
111.10M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Agenus | 316 |
| Gossamer Bio | 145 |
| Fortress Biotech | 101 |
| Korro Bio | 87 |
| Precision BioSciences | 67 |
| Equillium | 35 |
| Oncolytics Biotech | 28 |
| Gain Therapeutics | 25 |
CDXS News
- 3 days ago - Codexis signs agreement to manufacture 50 g siRNA using its ECO Synthesis® Manufacturing Platform - PRNewsWire
- 10 days ago - Codexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11 - GlobeNewsWire
- 25 days ago - Codexis Achieves ISO 9001:2015 Certification - GlobeNewsWire
- 2 months ago - Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics - PRNewsWire
- 4 months ago - Codexis Announces Signing of Lease for GMP Manufacturing Facility - GlobeNewsWire
- 4 months ago - Codexis, Inc. (CDXS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis® Manufacturing Platform for Therapeutic siRNA Manufacturing - PRNewsWire
- 4 months ago - Codexis to Report Third Quarter 2025 Financial Results on November 6 - GlobeNewsWire